Slingshot members are tracking this event:
Merck's osteoporosis candidate odanacatib development terminated
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Sep 02, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Cathepsin K Inhibitor, Osteoporosis, Stroke, American Society For Bone Mineral Research